Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT05748171
Title	A Study to Learn More About the Study Medicine Called Inotuzumab Ozogamicin (InO) in Children (1 to <18 Years) With First Relapse ALL
Recruitment	Recruiting
Gender	both
Phase	Phase II
Variant Requirements	Yes
Sponsors	Pfizer
Indications	childhood B-cell acute lymphoblastic leukemia
Therapies	Asparaginase + Dexamethasone + Mitoxantrone + Vincristine Sulfate Inotuzumab ozogamicin
Age Groups:	child
Covered Countries	SWE \| SVK \| POL \| NOR \| NLD \| ITA \| ISR \| HUN \| GRC \| FRA \| FIN \| ESP \| DNK \| DEU \| CZE \| CHE \| BEL \| AUT